These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6977375)

  • 1. HLA-DR antigens on CLL lymphocytes.
    Johnstone AP
    Br J Haematol; 1982 Feb; 50(2):378-9. PubMed ID: 6977375
    [No Abstract]   [Full Text] [Related]  

  • 2. Random HLA-DR distribution in children with acute lymphocytic leukaemia in long-term continuous remission.
    de Jongh BM; van der Dose-van den Berg A; Schreuder GM
    Br J Haematol; 1982 Sep; 52(1):161-3. PubMed ID: 6956369
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute lymphoblastic leukemia and HLA].
    Qian FW; Ye GY; Kong FH
    Zhonghua Nei Ke Za Zhi; 1986 Apr; 25(4):217-9, 253-4. PubMed ID: 3461930
    [No Abstract]   [Full Text] [Related]  

  • 4. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
    Guy K; Docherty LJ; Dewar AE
    Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation antigens in acute leukaemia.
    Reen DJ
    Biochem Soc Trans; 1985 Apr; 13(2):420-2. PubMed ID: 3926556
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation by CLL cells in mixed lymphocyte culture (MLC).
    Jones EH; Hockley AB; Lawler SD
    Br J Cancer; 1981 Nov; 44(5):675-81. PubMed ID: 6172142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histocompatibility antigen frequencies in patients with chronic lymphocytic leukaemia: possible identification of a subgroup with relatively benign disease.
    Kilpatrick DC; Dewar AE; Stockdill G; Maginnis M; Jordan A; Neill GW; Gelsthorpe K; Yap PL
    Scand J Haematol; 1984 Oct; 33(4):391-6. PubMed ID: 6594744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple specificities of B lymphocyte-reactive antibodies and their significance in renal allograft survival.
    Rhodes CL; Goldman MH; Mendez-Picon G; Lee HM; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1425-6. PubMed ID: 6390841
    [No Abstract]   [Full Text] [Related]  

  • 11. A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells.
    Fuggle SV; Kirkley J; Ting A; Morris PJ
    Immunogenetics; 1983; 18(4):415-28. PubMed ID: 6195109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heated lymphocytes express HLA-DR antigens despite their inability to stimulate in MLC.
    Brewer JA; Hank JA; Wendel T; Schmeling GJ; Blank JL; Morrissey LW; Robins HI; Sondel PM
    Tissue Antigens; 1983 Oct; 22(4):246-56. PubMed ID: 6228035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
    Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA DR antigens in childhood acute lymphoblastic leukaemia long survival.
    De Bruyere M; Cornu G; Ninane J; Latinne D; Lebacq AM; Sokal G
    Br J Haematol; 1982 Aug; 51(4):659-61. PubMed ID: 6980667
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genetic factors linked to the HLA system conferring increased susceptibility to acute lymphoblastic leukemia in children].
    von Fliedner V; Mérica H; Jeannet M; Chapuis B; Feldges A; Imbach P; Wyss M
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1445-7. PubMed ID: 6417776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblasts.
    Orgad S; Yunis EJ; Zaizov R; Ramot B; Altshuler R; Gazit E
    Hum Immunol; 1984 Feb; 9(2):67-74. PubMed ID: 6421779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [B-lymphocyte immunology. Present status of knowledge].
    Májský A
    Vnitr Lek; 1981 Jul; 27(7):699-709. PubMed ID: 7029888
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA antigens in patients with adult T-cell leukemia.
    Tanaka K; Sato H; Okochi K
    Tissue Antigens; 1984 Jan; 23(1):81-3. PubMed ID: 6608165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic characteristics of hematopoietic stem cells].
    Tananov AT; Timakova LA
    Gematol Transfuziol; 1986 Feb; 31(2):48-53. PubMed ID: 2420680
    [No Abstract]   [Full Text] [Related]  

  • 20. The association of HLA-DR5 antigen with longer survival in childhood leukaemia.
    Révész T; Banczúr M; Gyódi E; Petrányi GG; Schuler D
    Br J Haematol; 1981 Jul; 48(3):508-10. PubMed ID: 6942874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.